Celyad Oncology SA (EBR: CYAD)
Belgium
· Delayed Price · Currency is EUR
0.650
-0.036 (-5.25%)
Nov 21, 2024, 5:35 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €28.42 million as of November 21, 2024. Its market cap has increased by 91.33% in one year.
Market Cap
28.42M
Enterprise Value
23.18M
Revenue
72.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.65
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 28.42M, a decrease of -72.13%. That is a compound annual growth rate of -10.62%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 33.42B |
UCB SA | 32.23B |
Financière de Tubize SA | 5.81B |
Fagron NV | 1.33B |
Ion Beam Applications SA | 383.44M |
Onward Medical N.V. | 159.29M |
Hyloris Pharmaceuticals SA | 145.04M |
Sequana Medical NV | 39.73M |